Drug Profile
Oxymorphone immediate-release - Ensysce Biosciences
Alternative Names: PFR 03323Latest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Ensysce Biosciences
- Class Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for research development in Pain in USA (PO, Immediate release)
- 24 Feb 2016 Early research in Pain in USA (PO) before February 2016